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The most common reason for people seeking the advice 
of health professionals is that they are in some sort of 
pain. In general, pain is symptom of some form of 
dysfunction and resultant inflammatory processes in the 
body1.  
Many drugs are available that help to reduce 
inflammation and relieve pain. They act by interfering 
with the body’s natural inflammatory response 
mechanisms; however their chronic use may lead to side 
effects.  
Over the past few years research suggest role for more 
natural and safe alternatives for the management of pain 
and inflammation. Some areas of research include 
supplemental essential fatty acids, herbs such as ginger, 
turmeric, and boswellia, proteases (trypsin, bromelain) 
and bioflavonoids (rutoside).  
Recent clinical studies show that the Bromelain, Trypsin 
and Rutoside fixed dose combination to be a very potent 
and safe in relieving oedema, inflammation and 
promoting wound healing. 
The anti-inflammatory effect of proteolytic enzymes has 
been proved by several clinical studies and is considered 
to a promising treatment for acute (e.g., sports) injuries, 
post-surgery and degenerative joint conditions2-7. 
Common proteases include bromelain from pineapple; 
trypsin, chymotrypsin from porcine (pig) or bovine 
(cow) origin. However, porcine sources yield higher 
specific activity than do bovine sources1.  
The individual therapeutic role of these natural 
substances was established long back in 1960s but in 
recent years further clinical studies were done to prove 
this role more substantially and now there is sufficient 
evidence that the combination of Bromelain, Trypsin and 
Rutoside has a significant implication in alleviate 
oedema and inflammation. 
In this article the anti-inflammatory activity of 
Bromelain, Trypsin and Rutoside as individual drugs and 
their fixed dose combination has been discussed. 
TRYPSIN: 
Trypsin is produced in the pancreas in the form of the 
inactive zymogen trypsinogen. When the pancreas is 
stimulated by cholecystokinin, it is then secreted into the 
duodenum via the pancreatic duct8. Once in the 
duodenum, the enzyme enteropeptidase activates it into 
trypsin by proteolytic cleavage. Trypsin in the duodenum 
catalyses the hydrolysis of peptide bonds so that proteins 
can be broken down into smaller peptides9.  
Clinical studies exhibit that the anti-inflammatory effect 
of trypsin is possibly due to inhibitory action on the 
vascular permeability10 and its ability to inhibit the rise 
in C-reactive protein and enhance the rise in alpha 1-
antitrypsin, alpha 2-macroglobulin11. Trypsin-
chymotrypsin has also been shown to modulate cytokine 
levels in burns4. 
BROMELAIN 
Bromelain is a crude extract from the pineapple that 
contains, among other components, various closely 
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related proteinases, demonstrating, in vitro and in vivo, 
antiedematous, antiinflammatory, antithrombotic and 
fibrinolytic activities12. 
Bromelain when applied topically as a cream (35% 
bromelain in a lipid base) is beneficial in the elimination 
of burn debris and in acceleration of healing13. Several 
groups have provided significant evidence for both the 
edema-protective and edema-reducing efficacy of 
bromelain in various animal experiments14.  
Bromelain is used as an anti-inflammatory and analgesic 
agent in treating the symptoms of arthritis31-33. The 
analgesic and anti-inflammatory effects are reportedly 
due to inhibition of the arachidonic acid pathway of 
inflammation by selectively decreasing thromboxane 
generation, changing the ratio of 
thromboxane/prostacyclin (in favor of prostacyclin), and 
inhibiting PGE2 in addition to the direct effects on the 
nociceptors 15,16. Other reported anti-inflammatory 
mechanisms of action of bromelain include inhibition of 
bradykinin at the site of inflammation via depletion of 
the plasma kallikrein system, and limiting the formation 
of fibrin by reduction of clotting cascade 
intermediates17,18. A few clinical trials in patients with 
arthritis reported statistical equivalence of pain 
reduction, whether they were treated with bromelain or 
diclofenac19. 
RUTOSIDE 
Rutoside is a natural flavone derivative. It has anti-
inflammatory, anti-allergy and immunomodulating 
activity 20. Rutoside inhibits platelet aggregation, as well 
as decreasing capillary permeability, making the blood 
thinner and improving circulation. Rutin also strengthens 
the capillaries. It helps to prevent venous edema of the 
legs. Thus, rutoside is useful in the management of 
venous edema and capillary fragility21.  
Rutoside is a powerful anti-oxidants and effectively 
combat the harmful free radicals such as nitric oxide, 
released during the inflammatory process 22,23. 
Rutoside also suppresses the major inflammatory and 
proarthritic mediators of macrophages24. The ability of 
Rutoside to decrease MCP-1 levels in vivo and in vitro 
may add to its beneficial effects because this cytokine is 
a potent stimulator of monocyte recruitment into the site 
of inflammation25. Rutoside also inhibit the 
phosphorylation and activation of Jun N-terminal 
kinase/stress-activated protein kinase, leading to the 
suppression of AP-1 activation. They also decrease the 
activation of NF-κB in both human and experimental 
models 26,27. 
COMBINATION OF TRYPSIN, RUTOSIDE AND 
BROMELAIN 
Combination of Trypsin, Rutoside and Bromelain has 
shown to have significant anti-inflammatory effects in 
several clinical studies. However, the combined 
mechanism of action of these agents is not clear and need 
to be explored further. 
In a clinical study conducted in 2004, the efficacy of an 
enzyme-flavonoid mixture was compared with 
diclofenac, a prescription NSAID28.The proteolytic 
enzymes used were bromelain and trypsin. These three 
agents were used in the form of an enteric-coated tablet 
(to prevent the enzymes from being destroyed by 
stomach acid) that contained 90 mg of bromelain, 48 mg 
of trypsin, and 100 mg of rutoside. 
For the 6-week trial, the researchers recruited 103 
middle-aged patients who   had painful osteoarthritis of 
the knee with a disease flare in one knee joint. The 
results showed that diclofenac and the 
bromelain/trypsin/rutoside mixture were about equally 
effective in relieving the patients’ pain and improving 
their mobility, with no serious adverse events in either 
case 28. 
In another clinical study conducted in 2006, the 
Phlogenzym- (PE-fixed dose combination of trypsin, 
bromelain and rutoside) was compared to the non-
steroidal anti-inflammatory drug (NSAID) diclofenac in 
patients with osteoarthritis of the hip. After six weeks of 
observation this trial showed significant non-inferiority 
from 6 weeks treatment with PE in patients with 
osteoarthritis of the hip and with regard to drug 
tolerability some tendencies in favour of PE. Thus, PE 
may well be recommended for the treatment of patients 
with osteoarthritis of the hip with signs of inflammation 
as indicated by a high pain level. 
CONCLUSION 
Over the past many decades anti inflammatory drugs 
NSAIDs are being used very extensively all over the 
world but their chronic use may lead to side effects such 
as gastric ulcers and liver- kidney damage. After bitter 
experiences with NSAIDs like Rofecoxib and 
Valdecoxib, virtually all NSAIDs come with a warning 
about potential increased risks of heart attack and stroke 
with their use. A recent study on the cardiovascular 
safety of NSAIDs has highlighted further evidence that 
diclofenac is associated with cardiovascular risks that are 
higher than the other non-selective NSAIDs, and similar 
to the selective COX-2 inhibitors30.Thus their frequent 
use is not recommended. Another group of drugs used in 
severe inflammatory conditions are steroids that 
contribute to even more severe and serious adverse 
effects on long-term use. 
Considering these facts, the use of drugs of natural origin 
with lesser hazards is a positive alternative. Bromelain, 
Rutoside and Trypsin are known to have a very 
promising role in relieving inflammation and promote 
wound healing and based on the clinical studies 
performed on their combination, the Bromelain, Rutoside 
and Trypsin combination might be a safer alternative in 
comparison to other drugs used for these conditions. 
Although further studies need to be done to determine 
how each individual drug affects the activity of another 
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